• Adacel

  Form: solution for injection in ampoule-syringe

  Active substance	Dosage
  Diphtheria toxoid	not less than 2 IU (2 Lf)/0.5 ml
  Tetanus toxoid	not less than 20 IU (5 Lf)/0.5 ml
  pertussis antigens	pertussis toxoid 2.5 mcg, filamentous hemagglutinin 5 mcg, pertactin 3 mcg, fimbriae type 2 and 3 5 mcg/0.5 ml

  ATC: J07AJ52

  Manufacturer: Sanofi Winthrop Industrie Sanofi-Aventis Zrt.

• Adacel polio

  Form: solution for injection in ampoule-syringe

  Active substance	Dosage
  diphtheria toxoid	Not less than 2 IU (2 Lf)
  tetanus toxoid	Not less than 20 IU (5 Lf)
  pertussis toxoid	2.5 mcg
  fibrillar hemagglutinin	5 mcg
  pertactin	3 mcg
  Fimbriae (type 2 and 3)	5 mcg
  Inactivated poliovirus type 1	29 units of D3 antigen
  Inactivated poliovirus type 2	7 units of D3 antigen
  Inactivated poliovirus type 3	26 units of D3 antigen

  ATC: J07CA02

  Manufacturer: Sanofi-Aventis Zrt.

• Boostrix

  Form: solution for injection in ampoule-syringe

  Active substance	Dosage
  diphtheria toxoid	No input provided
  tetanus toxoid	No input provided
  Bordetella pertussis antigens	No input provided

  ATC: J07AJ52

  Manufacturer: GlaxoSmithKline Biologicals S.A.

• Boostrix polio

  Form: solution for injection in ampoule-syringe

  Active substance	Dosage
  diphtheria toxoid	> or equal to 2 IU (2.5 Lf)
  aluminum phosphate	0.2 mg Al 3+
  inactivated poliovirus type 1	40 units of antigen D
  inactivated poliovirus type 2	8 units of antigen D
  inactivated poliovirus type 3	32 units of antigen D
  tetanus toxoid	> or equal 20 IU (5 Lf)
  aluminum hydroxide hydrate	0.3 mg Al 3+
  Bordetella pertussis antigens	8 mcg + 8 mcg + 2.5 mcg

  ATC: J07CA02

  Manufacturer: GlaxoSmithKline Biologicals S.A.

• Clodivac

  Form: suspension for injection

  Active substance	Dosage
  diphtheria toxoid	ad 10 ml
  tetanus toxoid	not less than 40 IU

  ATC: J07AM51

  Manufacturer: Institute of Biotechnology of Sera and Vaccines BIOMED S.A.

• Dt-diphtheria-tetanus vaccine adsorbed

  Form: suspension for injection

  Active substance	Dosage
  tetanus toxoid	not less than 40 IU
  diphtheria toxoid	not less than 30 IU

  ATC: J07AM51

  Manufacturer: Institute of Biotechnology of Sera and Vaccines BIOMED S.A.

• Dtp-diphtheria-tetanus-pertussis vaccine adsorbed

  Form: suspension for injection

  Active substance	Dosage
  Diphtheria toxoid	not less than 30 IU
  Tetanus toxoid	not less than 40 IU
  Inactivated Bordetella pertussis strain suspension	not less than 4 IU

  ATC: J07AJ51

  Manufacturer: Institute of Biotechnology of Sera and Vaccines BIOMED S.A.

• Dultavax

  Form: suspension for injection

  Active substance	Dosage
  Poliovirus type 1 Mahoney strain inactivated	1,245 g/10 ml
  Diphtheria toxoid	0.01 g/10 ml
  Poliovirus type 2 MEF-1 strain inactivated	ad 1 ml
  Tetanus toxoid	0.01 g/10 ml
  Poliovirus type 3 Sabin strain inactivated	32 units of antigen D

  ATC: J07CA01

  Manufacturer: Sanofi Pasteur Sanofi-Aventis Ltd.

• Infanrix - ipv + hib

  Form: powder and suspension for preparation of injection suspension

  Active substance	Dosage
  diphtheria toxoid	No input provided
  tetanus toxoid	No input provided
  Bordetella pertussis antigens	No input provided
  inactivated poliovirus types 1, 2 and 3	No input provided
  Haemophilus b polysaccharide conjugated with tetanus toxoid	No input provided

  ATC: J07CA06

  Manufacturer: GlaxoSmithKline Biologicals S.A.

• Infanrix ipv

  Form: suspension for injection

  Active substance	Dosage
  inactivated poliovirus type 1	40 units of antigen D
  inactivated poliovirus type 2	8 units of antigen D
  inactivated poliovirus type 3	32 units of antigen D
  Diphtheria toxoid	or equal to 30 IU
  Tetanus toxoid	or equal to 40 IU
  pertussis antigens	25 mcg + 25 mcg + 8 mcg

  ATC: J07CA02

  Manufacturer: GlaxoSmithKline Biologicals S.A.

• Neisvac-c

  Form: suspension for injection

  Active substance	Dosage
  tetanus toxoid	10 - 20 mcg
  polysaccharide (O-deacetylated) Neisseria meningitidis group C (strain C11)	10 mcg

  ATC: J07AH07

  Manufacturer: Pfizer Manufacturing Belgium NV

• Pentaxim

  Form: powder and suspension for preparation of injection suspension

  Active substance	Dosage
  Inactivated poliovirus type 1	40 units of antigen D
  Inactivated poliovirus type 2	8 units of antigen D
  Inactivated poliovirus type 3	32 units of antigen D
  Haemophilus influenzae type b conjugated polysaccharide-tetanus toxoid conjugate	10 mcg
  Diphtheria toxoid	not less than 30 IU
  Tetanus toxoid	not less than 40 IU
  Bordetella pertussis antigens	25 mcg + 25 mcg

  ATC: J07CA02

  Manufacturer: Sanofi Winthrop Industrie

• Tdap vaccine

  Form: solution for injection in ampoule-syringe

  Active substance	Dosage
  diphtheria toxoid	Not less than 2 IU
  tetanus toxoid	Not less than 20 IU
  pertussis toxoid	20 mcg

  ATC: J07AJ52

  Manufacturer: AJ Vaccines A/S

• Tetana

  Form: suspension for injection

  Active substance	Dosage
  tetanus toxoid	not less than 40 IU

  ATC: J07AM01

  Manufacturer: Institute of Biotechnology of Sera and Vaccines BIOMED S.A.

• Tetana pro

  Form: suspension for injection

  Active substance	Dosage
  tetanus toxoid	10 Lf (40 IU)

  ATC: J07AM01

  Manufacturer: Institute of Biotechnology of Sera and Vaccines BIOMED S.A.

• Tetanus vaccine adsorbed (t)

  Form: suspension for injection

  Active substance	Dosage
  tetanus toxoid	not less than 40 IU

  ATC: J07AM01

  Manufacturer: Biomed Ltd., Manufacturer of Sera and Vaccines

• Tetraxim

  Form: solution for injection in ampoule-syringe

  Active substance	Dosage
  diphtheria toxoid	minimum 30 IU
  tetanus toxoid	minimum 40 IU
  Bordetella pertussis antigens	25 micrograms
  poliovirus type 1 Mahoney strain inactivated	40 units of antigen D
  poliovirus type 2 MEF-1 strain inactivated	8 units of antigen D
  poliovirus type 3 Sabin strain inactivated	32 units of antigen D

  ATC: J07CA02

  Manufacturer: Sanofi Winthrop Industry Sanofi Winthrop Industry Sanofi-Aventis Ltd.